Pneumonia is one of the most commonly acquired diseases in nursing homes. This is a serious problem for nursing homes, residents, families and Philadelphia nursing home negligence attorneys, because pneumonia can also be a life-threatening disease in older people and people in poor health. In fact, the health care community has made nursing-home-acquired pneumonia a distinct subcategory of pneumonias, because pneumonia in this group is most likely to come from contact with health care facilities, and because pneumonia can have different symptoms in people with dementia and the very elderly.
That is why we were interested in a study about pneumonia published in the American Journal of Respiratory and Critical Care Medicine. Researchers in the Netherlands found that a steroid drug commonly used to fight the disease did not improve the patients’ health. In fact, the Dutch researchers found that patients taking prednisolone had a significantly greater chance of their symptoms recurring after three days of treatment. The study looked at the use of prednisolone versus a placebo in 213 hospitalized patients with all levels of pneumonia severity. The researchers concluded that prednisolone should not be used routinely.
Our Pennsylvania nursing home neglect attorneys are already slightly suspicious of homes with a large number of pneumonia cases. The preventive measures tend to be common sense measures like hand-washing — which calls into question the practices at facilities with severe or chronic problems. This study suggests that nursing homes and hospitals that treat nursing home residents should carefully consider whether prenisolone does more harm than good to patients. If more studies turn up this problem, homes should seriously consider stopping routine use of prenisolone altogether.
Rosenbaum & Associates represents nursing home residents and families that suffered serious injuries or a loss because of a nursing home’s carelessness or law-breaking. To learn more or set up a consultation, please call us at 1-800-7-LEGAL-7 or contact us through our Web site.